Anbio Biotechnology — Investor Relations & Filings
Anbio Biotechnology is a medical device company specializing in the development and provision of in-vitro diagnostic (IVD) solutions. The company's portfolio includes a diverse range of diagnostic instruments and assays for laboratory, point-of-care (POCT), and over-the-counter (OTC) applications. Its products are designed to detect biomarkers across numerous medical fields, such as infectious diseases, cancer, cardiovascular diseases, inflammation, and endocrine disorders. Anbio utilizes five core technology platforms: Chemiluminescence Immunoassay (ChLIA), Lateral Flow Immunoassay (LFIA), Fluorescent Immunoassay (FIA), Polymerase Chain Reaction (PCR), and Loop-mediated Isothermal Amplification (LAMP). The company focuses on advancing medical technology by creating personalized and decentralized diagnostic tools to enhance patient care and outcomes globally.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| FORM 6-K | 2026-05-19 | English | |
| 6-K - Anbio Biotechnology (0001982708) (Filer) | 2026-04-27 | English | |
| 20-F/A - Anbio Biotechnology (0001982708) (Filer) | 2026-04-09 | English | |
| 20-F - Anbio Biotechnology (0001982708) (Filer) | 2026-04-07 | English | |
| 6-K Filing | 2026-02-17 | English | |
| FORM 6-K | 2026-01-26 | English |
Browse filings by year
4 years| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
6 filings
| |||||
| 46531517 | FORM 6-K | 2026-05-19 | English | ||
| 37622223 | 6-K - Anbio Biotechnology (0001982708) (Filer) | 2026-04-27 | English | ||
| 33898496 | 20-F/A - Anbio Biotechnology (0001982708) (Filer) | 2026-04-09 | English | ||
| 33744310 | 20-F - Anbio Biotechnology (0001982708) (Filer) | 2026-04-07 | English | ||
| 32276891 | 6-K Filing | 2026-02-17 | English | ||
| 13663206 | FORM 6-K | 2026-01-26 | English | ||
|
2025
9 filings
| |||||
| 13663207 | REPORT OF FOREIGN PRIVATE ISSUER | 2025-12-30 | English | ||
| 13663208 | REPORT OF FOREIGN PRIVATE ISSUER | 2025-11-13 | English | ||
| 13663209 | ANNUAL REPORT | 2025-04-28 | English | ||
| 13663210 | REPORT OF FOREIGN PRIVATE ISSUER | 2025-02-21 | English | ||
| 13663211 | PROSPECTUS | 2025-02-19 | English | ||
| 13663212 | Regulatory Filings 2025 | 2025-02-19 | English | ||
| 13663213 | Regulatory Filings 2025 | 2025-02-18 | English | ||
| 13663214 | Regulatory Filings 2025 | 2025-02-14 | English | ||
| 13663215 | Regulatory Filings 2025 | 2025-02-14 | English | ||
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
AC Immune SA
Biopharmaceutical firm developing precision medicine for ne…
|
ACIU | CH | Manufacturing |
|
Aclaris Therapeutics, Inc.
Clinical-stage biopharmaceutical company developing drugs f…
|
ACRS | US | Manufacturing |
|
Acrivon Therapeutics, Inc.
Clinical-stage biopharma using proteomics to develop precis…
|
ACRV | US | Manufacturing |
|
ACRUX LIMITED
Develops and commercializes topical and transdermal drug de…
|
ACR | AU | Manufacturing |
|
Acticor Biotech
Develops treatments for thrombotic diseases, focusing on ac…
|
ALACT | FR | Manufacturing |
|
Actinium Pharmaceuticals, Inc.
Clinical-stage company developing targeted radiotherapies f…
|
ATNM | US | Manufacturing |
|
ACTUATE THERAPEUTICS, INC.
Clinical-stage biopharma developing therapies for cancers w…
|
ACTU | US | Manufacturing |
|
AcuCort AB
Develops user-friendly drug formulations for severe and acu…
|
ACUC | SE | Manufacturing |
|
Acumen Pharmaceuticals, Inc.
Clinical-stage biopharma developing targeted therapies for …
|
ABOS | US | Manufacturing |
|
Acurx Pharmaceuticals, Inc.
Clinical-stage biopharma developing a new class of antibiot…
|
ACXP | US | Manufacturing |
Anbio Biotechnology via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/31914/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=31914 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=31914 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=31914 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 31914}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Anbio Biotechnology (id: 31914)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.